Passkey Therapeutics
Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics or SMThs, designed to address complex diseases by targeting rare combinations of proteins that work together. Using its proprietary Locksmith platform, the company is advancing programs across multiple therapeutic areas to create new options for patients with common, hard-to-treat conditions.
7-day free trial · no credit card
Verified contacts
15
available on Kipplo
LinkedIn employees
10
11 to 50 range
Open roles
—
no listings
Distinct roles
8
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 15 verified contacts at Passkey Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
15 contacts with verified email or phone · masked until revealed.
- NM
Nghia Millard
Data Scientist · Information Technology
EmailPhone - FM
Finola Moore
Senior Director, Biology · Other
EmailPhone - PD
Peter Dandliker
Chief Operating Officer · General Business & Management
EmailPhone - JY
Joel Yeshman
Senior Director Finance · Finance & Accounting
EmailPhone - JB
John Burnell
Research Associate · Science
EmailPhone - VP
Valeria Padovano
Senior Scientist · Research & Development
EmailPhone - JL
Jeff Livingstone
() · Other
EmailPhone - SR
Soumya Ray
Co-founder and Interim CTO · Other
EmailPhone
Showing 8 of 15 verified contacts
Top roles at Passkey Therapeutics
8 distinct titles indexed · top 8 shown.
- 1()
- 1chief operating officer
- 1co-founder and interim cto
- 1data scientist
- 1research associate
- 1senior director finance
- 1senior director, biology
- 1senior scientist
Sign up to unlock all 15 contacts at Passkey Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 15 verified contacts at Passkey Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.